https://www.selleckchem.com/pr....oducts/fadraciclib.h
Using the ROC curve, the patients are separated into two populations and the comparison of the survival curves is statistically significant ([Formula see text]). The baseline exam seems to have a significant role in the prediction of response to TKI treatment. More precisely, our imaging biomarker defined using only the CT scan before the TKI introduction allows to determine a first classification of the population which is improved over time using the imaging marker as soon as more CT scans are available. This exploratory study lea